Passage Bio, Inc.PASGNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank29
3Y CAGR-26.1%
5Y CAGR-8.0%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-26.1%/yr
vs +170.0%/yr prior
5Y CAGR
-8.0%/yr
Recent deceleration
Acceleration
-196.2pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
4 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$19.88M-20.5%
2024$24.99M-39.9%
2023$41.58M-15.7%
2022$49.34M-17.8%
2021$60.06M+99.4%
2020$30.11M+333.2%
2019$6.95M+649.0%
2018$928000.00-